HOPKINTON, Mass., Feb. 15, 2021 /PRNewswire/ — Lykan Bioscience, a contract Manufacturing Providers Group™ (MSO) and supplier of the primary true end-to-end answer for the manufacture of cell-based therapies, welcomes Keith McCormick as Chief Monetary Officer. Keith brings greater than 30 years of finance expertise with management positions in a number of main corporations throughout a variety of industries, geographies, and monetary disciplines.
As CFO, Keith is chargeable for the integrity of the corporate’s monetary reporting and enterprise management processes whereas partnering with the management crew in all points of the corporate’s administration together with technique, contracting, funding, operations administration and buyer satisfaction.
Previous to becoming a member of Lykan, Keith spent 18 months consulting with rising biotechnology corporations as they scaled up operations. Previous to that, he spent 6 years with Patheon Prescribed drugs, which was acquired by Thermo Fisher Scientific. As VP of Finance at Patheon, he supported the worldwide Pharmaceutical Growth Providers (PDS) enterprise unit and led the preliminary formation of company FP&A and business finance. Keith originates from the UK the place he certified as a Chartered Accountant and spent 20 years in hi-tech organizations in Scotland, Switzerland, Germany, and the U.S.
“Keith is a extremely completed finance govt with in depth expertise in company finance. He joins Lykan at a time of great alternative and progress for the corporate. His enterprise and monetary experience will likely be instrumental in serving to us to proceed to develop the corporate” stated Lykan Bioscience President & COO Patrick Lucy. “We’re happy to welcome Keith to the crew and stay up for his management and contributions.”
“I’m extraordinarily excited to be becoming a member of the Lykan crew and stay up for the corporate’s continued progress as we mature to be one of many main cell remedy producers within the trade,” stated Keith McCormick.
About Lykan Bioscience
Lykan Bioscience is a privately held contract Manufacturing Providers Group™ (MSO) situated in Hopkinton, MA. The Lykan crew gives a long time of biopharmaceutical trade expertise in facility design, high quality operations, and engineering, and the primary true end-to-end answer supplier for cell-based therapies.
The corporate’s SMART Manufacturing™ purpose-built facility that has been uniquely designed to totally combine CGMP ideas and superior software program options. Our software program utility platform permits for well timed entry to information, logistics, and experience in driving remedies from medical manufacturing by means of to business manufacturing.
Lykan Bioscience and our purchasers are Remodeling the Future Collectively™, as we work collaboratively to supply new life-saving therapies to sufferers worldwide. For additional info, please go to www.lykanbio.com
SOURCE Lykan Bioscience